Companies: 10,822     total market cap: โ‚น14101.849 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Sarepta Therapeutics
SRPT
#4862
Rank
โ‚น187.66 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
โ‚น1,778
Share price
-0.85%
Change (1 day)
-41.79%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Revenue for Sarepta Therapeutics (SRPT)

Revenue in 2025 (TTM): โ‚น191.28 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น209.17 Billion. an increase over the revenue in the year 2024 that were of โ‚น163.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sarepta Therapeutics from 1997 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น197.33 B20.94%
2024 โ‚น163.16 B57.64%
2023 โ‚น103.50 B34.06%
2022 โ‚น77.20 B47.79%
2021 โ‚น52.24 B32.26%
2020 โ‚น39.49 B45.45%
2019 โ‚น27.15 B29.02%
2018 โ‚น21.04 B113.26%
2017 โ‚น9.87 B2579.36%
2016 โ‚น0.36 B342.41%
2015 โ‚น83.26 M-86.53%
2014 โ‚น0.61 B-29.61%
2013 โ‚น0.87 B-57.02%
2012 โ‚น2.04 B-17.78%
2011 โ‚น2.48 B88.55%
2010 โ‚น1.31 B61.54%
2009 โ‚น0.81 B-20.13%
2008 โ‚น1.02 B137.01%
2007 โ‚น0.43 B8342.88%
2006 โ‚น5.1 M-97.63%
2005 โ‚น0.21 B1054.73%
2004 โ‚น18.64 M-57.78%
2003 โ‚น44.15 M10.04%
2002 โ‚น40.12 M17.78%
2001 โ‚น34.07 M-43.73%
2000 โ‚น60.54 M596.4%
1999 โ‚น8.69 M-48.88%
1998 โ‚น17 M44.26%
1997 โ‚น11.78 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Gilead Sciences
GILD
โ‚น2.801 T 1,239.30%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚น164.68 B-21.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น103.07 B-50.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น407.93 B 95.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
โ‚น57.70 B-72.41%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น83.24 B-60.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
โ‚น1.78 B-99.15%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com